Related Experiment Video
Updated: Jun 6, 2026
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Molecular-Structural MRI Mismatch for Preoperative Risk Stratification of Pediatric Neuroblastoma
Junjie Wen1, Wenqi Wang2, Xuan Jia2
1Key Laboratory for Biomedical Engineering of Ministry of Education, Department of Biomedical Engineering, College of Biomedical Engineering & Instrument Science, Zhejiang University, Room 418, Teaching Building 6, Yuquan Campus, 38 Zheda Road, Hangzhou 310027, Zhejiang, China.
Molecular-structural mismatch imaging shows promise for noninvasively differentiating pediatric neuroblastoma risk groups. This novel MRI technique aids in assessing tumor risk stratification for better patient outcomes.
Area of Science:
- Radiology
- Pediatric Oncology
- Medical Imaging
Background:
- Neuroblastoma risk stratification is crucial for guiding treatment decisions in pediatric oncology.
- Accurate preoperative assessment of neuroblastoma risk remains a clinical challenge.
- Novel imaging biomarkers are needed for noninvasive risk stratification.
Purpose of the Study:
- To develop molecular-structural mismatch indexes using MRI.
- To evaluate the potential of these indexes for preoperative risk stratification in pediatric neuroblastoma.
- To compare the performance of mismatch indexes against conventional MRI techniques.
Main Methods:
- Prospective study involving 102 pediatric patients with suspected neuroblastoma.
- Structural MRI and amide proton transfer (APT) MRI were performed.
- A four-pool Lorentzian fitting model generated APT maps and APT-weighted (APTw) images.
- Molecular-structural mismatch images were synthesized from APT and structural MRI data.
- Receiver operating characteristic (ROC) analysis assessed risk stratification performance.
Main Results:
- Analysis included 71 participants (42 high-risk, 29 non-high-risk).
- Mean tumor values on APT, APTw, and mismatch images were significantly higher in high-risk patients (P < .05).
- Molecular-structural mismatch images demonstrated higher area under the curve (AUC) values (0.84 for APTw-T2w, 0.83 for APT-T2w) compared to APTw (0.68) and APT map (0.76) alone.
Conclusions:
- Molecular-structural mismatch imaging shows potential as a noninvasive tool for differentiating pediatric neuroblastoma risk groups.
- This novel approach may improve preoperative risk stratification, aiding in personalized treatment strategies.
- Further validation is warranted to integrate this technique into clinical practice.
